Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,400

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

September 5, 2024

Study Completion Date

July 31, 2028

Conditions
Coronary Artery DiseaseIschemic Heart Disease
Interventions
DEVICE

DynamX Bioadaptor

DynamX Bioadaptor Treatment

DEVICE

Resolute Onyx

Resolute Onyx Treatment

Trial Locations (19)

Unknown

Mälarsjukhuset Eskilstuna, Eskilstuna

Hallands sjukhus, Halmstad

Helsingborgs lasarett, Helsingborg

Blekingesjukhuset i Karlskrona, Karlskrona

Centralsjukhuset Karlstad, Karlstad

Skånes Universitetssjukhus i Lund, Lund

Skånes Universitetssjukhus i Malmö, Malmo

Universitetssjukhuset Örebro, Örebro

Östersunds sjukhus, Östersund

Sunderby sjukhus, Södra Sunderbyn

Capio St Görans sjukhus, Stockholm

Danderyds sjukhus, Stockholm

Karolinska Universitetssjukhuset Huddinge, Stockholm

Karolinska Universitetssjukhuset Solna, Stockholm

Södersjukhuset, Stockholm

Sundsvall Hospital, Sundsvall

Norrlands universitetssjukhus Umeå, Umeå

Akademiska Sjukhuset, Uppsala

Västmanlands sjukhus i Västerås, Västerås

Sponsors
All Listed Sponsors
collaborator

Uppsala University

OTHER

lead

Elixir Medical Corporation

INDUSTRY

NCT04562805 - Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT) | Biotech Hunter | Biotech Hunter